Clinical Trial Update: Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial reports on the effect of telmisartan on inflammatory parameters in hypertensive patients, including those with metabolic syndrome an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Hypertriglyceridemia
• Metabolic Syndrome

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Hypertension, Metabolic Syndrome | Phase 3 | Status: COMPLETED